Jean-Jacques Muyembe-Tamfum

Jean-Jacques Muyembe-Tamfum is a Congolese microbiologist and virologist, renowned for his pioneering work in the field of Ebola virus research. He has made significant contributions to the understanding and management of viral hemorrhagic fevers in the Democratic Republic of the Congo (DRC) and globally.
Early Life and Education[edit]
Jean-Jacques Muyembe-Tamfum was born in the DRC. He pursued his medical degree at the University of Lovanium (now University of Kinshasa), where he developed an interest in infectious diseases. He later obtained a Ph.D. in virology from the University of Leuven in Belgium.
Career[edit]
Muyembe-Tamfum began his career as a researcher at the Institut National de Recherche Biomédicale (INRB) in Kinshasa. He played a crucial role in the identification of the Ebola virus during the first recorded outbreak in 1976 in Yambuku, DRC. His work has been instrumental in the development of diagnostic techniques, treatments, and vaccines for Ebola.
Contributions to Ebola Research[edit]
Muyembe-Tamfum's research has focused on the epidemiology, pathogenesis, and control of Ebola virus. He was a key figure in the development of the Ebola vaccine and has been involved in numerous outbreak responses, providing expertise and leadership.
Leadership Roles[edit]
He has held several prominent positions, including Director-General of the INRB and Professor of Microbiology at the University of Kinshasa. Muyembe-Tamfum has also served as an advisor to the World Health Organization (WHO) on Ebola and other viral hemorrhagic fevers.
Awards and Recognition[edit]
Muyembe-Tamfum has received numerous awards for his contributions to science and public health, including the Légion d'honneur from France and the Hideyo Noguchi Africa Prize.
Related Pages[edit]
- Ebola virus
- Viral hemorrhagic fevers
- Institut National de Recherche Biomédicale
- University of Kinshasa
- World Health Organization
See Also[edit]
References[edit]
External Links[edit]
Jean-Jacques Muyembe-Tamfum[edit]
-
Jean-Jacques Muyembe-Tamfum
-
Ebola Virus - Electron Micrograph
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
